Pneumonia Vaccine

Researchers are studying an investigational vaccine that may provide protection against pneumococcal disease in healthy adults age 50 and older. This study will test the safety and immune response of three different lots of an investigational pneumonia vaccine compared to a vaccine already approved for use.

This clinical trial is open to healthy males and females over the age of 50 who have never received a pneumonia vaccine of any kind. Participation in this trial requires two visits to our clinic, with compensation of $275 provided for time and travel. No insurance is required.

If this study is of interest, please complete the form and one of our research study coordinators will be in touch to discuss further. The study doctor will review additional criteria with you to determine whether you can participate in the study.

Learn about the Clinical Trial Process at CCRN.

Learn about Clinical Trials